Daniel Chemtob

Biographic Data

ID337369
NAMEDaniel Chemtob
GIVEN NAMESDaniel
FAMILY NAMEChemtob
SIGNATURECHEMTOB D
AFFILIATIONSHebrew University of Jerusalem
ORCID0000-0002-2864-9982
VERIFIEDYes
TOTAL WORKS6
TOTAL CITATIONS0
AUTHOR COUNT6
EDITOR COUNT0
FIRST PUBLICATION YEAR1990
LATEST PUBLICATION YEAR2022
H-INDEX0

  • Drop-out of medical follow-up among people living with HIV in Tel-Aviv area

    Daniel Chemtob, Itzchak Levy et al.ARTICLEAIDS Care2022

    Access to HIV anti-retroviral treatment (ART) has significantly improved survival and the quality of life of people living with HIV (PLHIV). However, effective therapy necessitates high adherence to ART. The aim of this study was to identify the extent to which PLHIV in Israel were not retained in therapy and their obstacles to accessing care. The Department of Tuberculosis and AIDS (DTA) and the two existing HIV clinics in the Tel-Aviv metropoli…

  • Impact of Covid-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel

    Open AccessLucas Wiessing, Vana Sypsa et al.ARTICLEAIDS and Behavior2022

  • Cost utility analysis of HIV pre exposure prophylaxis among men who have sex with men in Israel

    Open AccessG M Ginsberg, Daniel ChemtobARTICLEBMC Public Health2020

    Despite PrEPs high effectiveness against HIV, PrEP was found not to be cost-effective in the Israeli context because of a combination of relatively low HIV incidence, high PrEP costs, with a likelyhood that some low-risk MSM (ie: who use condoms) may well begin taking PrEP and as a consequence many of these will abandon condom use. Therefore, ways of minimizing these last two phenomena need to be found

  • HIV prevalence in the Israeli tuberculosis cohort, 1999–2011

    Open AccessZohar Mor, Mor Zohar et al.ARTICLEBMC Public Health2014

    Most TB/HIV co-infected patients were migrants originating in high-burden countries. Despite the moderate 4.6% TB/HIV co-infection rate in Israel, these patients had worse treatment outcomes and higher mortality rates. This study illustrates the importance of integrating TB with HIV in surveillance and treatment components, which should be employed in other countries, as it has a positive impact on disease control

  • Voyage vers un autre univers de santé: Exemple d'une approche transculturelle de problèmes de Santé Publique

    Open AccessDaniel Chemtob, Haïm Rosen et al.ARTICLERevue européenne des migrations…1996

    Voyage vers un autre univers de santé : Exemple d'une approche transculturelle de problèmes de Santé Publique Daniel CHEMTOB, Haïm ROSEN, Antoine LAZARUS Ce travail est basé sur l'hypothèse suivante : si des autorités médicales occidentales veulent mettre plus efficacement en place des mesures de prévention auprès de populations migrantes originaires de pays en voie de développement, elles doivent développer des outils de communication culturelle…

  • Research note: Blood drawing and hepatitis B -- the case of Ethiopian Jews in Israel

    Open AccessDaniel Chemtob, Iris Kalka et al.ARTICLESociology of Health & Illness1990

    This paper describes the first stage of a prospective study created to evaluate a public health problem - hepatitis B virus (HBV) infection - and to design a strategy of prevention suitable for the target population, Ethiopian Jews in Israel. In the first stage of the study serological tests were conducted on 165 Ethiopian Jews, all of whom were residing in one location. This stage was designed to estimate the prevalence of HBV infection and to i…